Stocks
GlaxoSmithKline (GSK) ROE US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 29.1% | 46.4% | 46.4% | 36.9% | 36.9% | 23.2% | ||
| Changes by years, y/y, % | 0pp | +17pp | 0pp | -10pp | 0pp | -15.0% | |||
GlaxoSmithKline. ROE, %
GlaxoSmithKline. ROE, changes, pp
GlaxoSmithKline (GSK) ROE US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| ROE, % | ? | 42.2% | 46.0% | 36.9% | 36.9% | 32.4% | 23.2% | |
| Changes by years, y/y, % | +14pp | -14pp | -13pp | -13pp | -6pp | |||
| Changes by quarters, q/q, % | 0pp | +4pp | -9pp | 0pp | -5pp | |||
